New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Allurion Technologies Inc.
ALUR
Shape
US Flag

NYSE

Unprofitable

Unprofitable

25M

Medical - Devices

Next Earning date - 20 Mar 2025

25M

Medical - Devices

Next Earning date - 20 Mar 2025

5.15USD

Shape-0.08 ( -1.53%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

0
favorite-chart

Volume Buzz

-93%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

95%

Quote Panel

Shape
Updated February 17, 2025
1W 2.18 % 1M 73.99 % 3M -46.07 % 1Y -93.18 %

Key Metrics

Shape
  • Market Cap

    24.68M


  • Shares Outstanding

    4.79M


  • Share in Float

    4.02M


  • Dividende

    0


  • Earning Date

    20 Mar 2025


  • Price Target

    5.15


  • Average Volume

    1.44M


  • Beta

    -0.728


  • Range

    2.367-98.75


  • Industry

    Medical - Devices


  • Website

    https://www.allurion.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ALUR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$32M

Shape500%

2025-Revenue

$7.39

Shape-5177%

2025-EPS

$7M

Shape24%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Chardan Capital

downgrade

Previous: Buy

2024-11-14

Now: Positive

Cowen & Co.

initialise

Previous: Not converted

2024-10-02

Now: Buy

Chardan Capital

initialise

Previous: Not converted

2024-04-04

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.58
vs -0.14

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

-2.17
vs -0.29

Q3.23

arrow
arrow

N/A

-15.25
vs -0.11

Q4.23

arrow
arrow

N/A

-15.75
vs -0.58

Q1.24

arrow
arrow

N/A

2.75
vs NA

Q2.24

arrow
arrow

+112%

0.25
vs -2.17

Q3.24

arrow
arrow

N/A

-3.50
vs -15.25

Q4.24

arrow
arrow

N/A

-5.34
vs -15.75

Q1.25

arrow
arrow

N/A

-2.00
vs 2.75

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

19.2M  vs NA

Q1.23

arrow
arrow

+11%

14.1M  vs 12.7M

Q2.23

arrow
arrow

-20%

13M  vs 16.3M

Q3.23

arrow
arrow

+13%

18.2M  vs 16.1M

Q4.23

arrow
arrow

-57%

8.2M  vs 19.2M

Q1.24

arrow
arrow

-33%

9.4M  vs 14.1M

Q2.24

arrow
arrow

-9%

11.8M  vs 13M

Q3.24

arrow
arrow

-71%

5.4M  vs 18.2M

Q4.24

arrow
arrow

-26%

6.1M  vs 8.2M

Q1.25

arrow
arrow

-38%

5.8M  vs 9.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+17%

0.17
vs -0.02

Q1.23

arrow
arrow

+20%

0.2
vs 0.17

Q2.23

arrow
arrow

+20%

0.2
vs 0.2

Q3.23

arrow
arrow

+41%

0.41
vs 0.2

Q4.23

arrow
arrow

+27%

0.27
vs 0.41

Q1.24

arrow
arrow

-8%

-0.08
vs 0.27

Q2.24

arrow
arrow

+3%

0.03
vs -0.08

Q3.24

arrow
arrow

+14%

0.14
vs 0.03

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

ALUR

businesswire.com

8 hours ago